Benjamin Burnett
Stock Analyst at Stifel
(2.11)
# 2,763
Out of 4,786 analysts
71
Total ratings
42.86%
Success rate
-6.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Maintains: Hold | $5 → $3 | $0.77 | +287.75% | 3 | Mar 6, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $53 → $49 | $33.90 | +44.54% | 6 | Feb 13, 2025 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $63.09 | +93.37% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $18.50 | +273.07% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $14.93 | +355.46% | 7 | Sep 10, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.37 | +237.00% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $5.97 | +863.15% | 4 | Apr 1, 2024 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $4.65 | +16,658.34% | 2 | Sep 10, 2021 | |
| BLUE bluebird bio | Upgrades: Buy | $1,880 → $1,400 | $4.99 | +27,956.11% | 3 | Mar 27, 2020 | |
| RVMD Revolution Medicines | Maintains: Buy | $78 → $64 | $34.57 | +85.13% | 5 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $94 | $48.30 | +94.62% | 7 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4 | $1.04 | +286.47% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.44 | +594.44% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.32 | +653.01% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $24 | $0.66 | +3,528.12% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $0.57 | +2,692.81% | 1 | Jan 6, 2021 |
Fate Therapeutics
Mar 6, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $0.77
Upside: +287.75%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53 → $49
Current: $33.90
Upside: +44.54%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $63.09
Upside: +93.37%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $18.50
Upside: +273.07%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $14.93
Upside: +355.46%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.37
Upside: +237.00%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $5.97
Upside: +863.15%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $4.65
Upside: +16,658.34%
bluebird bio
Mar 27, 2020
Upgrades: Buy
Price Target: $1,880 → $1,400
Current: $4.99
Upside: +27,956.11%
Revolution Medicines
Apr 1, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $34.57
Upside: +85.13%
Jan 24, 2025
Maintains: Buy
Price Target: $90 → $94
Current: $48.30
Upside: +94.62%
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.04
Upside: +286.47%
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.44
Upside: +594.44%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $3.32
Upside: +653.01%
Jun 28, 2021
Upgrades: Buy
Price Target: $22 → $24
Current: $0.66
Upside: +3,528.12%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $0.57
Upside: +2,692.81%